AdaptHealth buys respiratory equipment distribution platform AeroCare

The combined company will operate as AdaptHealth while AeroCare CEO Steve Griggs will now serve as co-CEO. Credit: Bruno / Germany / Pixabay.

AdaptHealth has acquired US-based respiratory and home medical equipment (HME) distribution platform AeroCare for a total consideration consisting of approximately $1.1bn in cash and 31 million shares of AdaptHealth stock.

Free Whitepaper

Precision Medicine: Streamlining Treatments and Drug Development

Precision medicine has the potential to radically change the way health services are delivered, combining medical expertise with the latest technology to provide bespoke treatments for individual patients.

Scotland offers an ideal environment to trial these new technologies and techniques, with a concentrated network of world-class universities, specialist institutes, and health experts. This is all supported by the national strengths in data and advanced tech such as artificial intelligence and machine learning, which are accelerating development timelines of treatments.

Then there is the funding support available. Partnerships with universities allow companies to apply for UK funding streams. And Scottish universities have a track record of securing UK funding. In the last five years, through the Biotechnology and Biological Sciences Research Council and Medical Research Council, 13% (£450m) of all UK funding has gone to universities in Scotland.

Download to learn more.

By Scotland Health Tech

By downloading this case study, you acknowledge that GlobalData may share your information with Scotland Health Tech and that your personal data will be used as described in their Privacy Policy Visit our Privacy Policy for more information about our services, how GlobalData may use, process and share your personal data, including information on your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

With the development, AeroCare’s shareholders, including management and employees, and private investors Peloton Equity, SkyKnight Capital, SV Health Investors, and investment funds managed by Morgan Stanley AIP Private Markets’ Secondaries Team, will become shareholders in AdaptHealth.

Founded in 2000, AeroCare provides a complete suite of direct-to-patient equipment and services such as CPAP and BiPAP machines, oxygen concentrators, home ventilators, and other durable medical equipment products.

The company offers services to one million patients annually from more than 300 locations across 30 states and through affiliated websites online.

With the acquisition, the combined company will operate as AdaptHealth while AeroCare CEO Steve Griggs will now serve as co-CEO with AdaptHealth CEO Luke McGee to lead the company.

Griggs said: “The combined company is positioned to transform our industry and positively impact the lives of chronically ill patients across the country.

“Our management team and employees look forward to working with AdaptHealth to build an even stronger business, sharing best practices across each organisation to drive operational efficiencies and create enhanced opportunities for our patients, referral sources, and other stakeholders.”

Furthermore, the combined company is the leading independent HME provider in the US, serving nearly three million patients from more than 500 locations across 46 states.

Last January, AdaptHealth acquired the Patient Care Solutions (PCS) business of McKesson. The acquisition added urological and ostomy products to AdaptHealth’s home medical equipment (HME) product portfolio.